Biotech

All Articles

Aligos trumpets period 2 MASH win, reducing liver body fat up to 46%

.Aligos Therapeutics is actually trumpeting a midstage succeed in metabolic-dysfunction associated s...

Basilea credit ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work building brand new antifungals has received a notable boost coming fro...

Capricor sells Europe liberties to late-stage DMD therapy for $35M

.Having already gathered up the united state civil liberties to Capricor Rehabs' late-stage Duchenne...

FDA fragments adcomm for Applied's uncommon health condition drug

.After pushing the decision meeting for Applied Rehabs' metabolic ailment medication govorestat, the...

Novo inks $600M NanoVation bargain to examine hereditary drugs ex-liver

.Novo Nordisk is proceeding its own press into genetic medications, accepting compensate NanoVation ...

Innovent links cytokine to colorectal cancer cells reactions

.Innovent Biologics has actually created the instance that its own gate inhibitor-cytokine blend hea...

Merck, Daiichi ADC reaches target in stage 3 lung cancer cells research

.A period 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina grows artificial intelligence center with collab to pick cancer cells targets

.Five months after Rakovina Therapies turned towards artificial intelligence, the cancer-focused bio...

Ascendis' dwarfism medicine hits in phase 3, threatens BioMarin

.Ascendis Pharma has emerged as a prospective risk to BioMarin's Voxzogo, mentioning period 3 develo...

Despite ph. 3 miss, Alkeus finds road ahead of time for eye condition possession

.Though Alkeus Pharmaceuticals' dental eye condition resource fell short to significantly minimize g...